Dashboard
Manage Tickers

NRIX Nurix Therapeutics, Inc.

Nasdaq nurixtx.com


$ 9.74 $ 0.58 (6.32 %)    

Wednesday, 15-Oct-2025 13:15:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 596.56 $ -7.26 (-1.2 %)
DIA $ 460.70 $ -3.94 (-0.85 %)
SPY $ 659.64 $ -7.14 (-1.07 %)
TLT $ 90.72 $ -0.24 (-0.26 %)
GLD $ 385.09 $ -0.83 (-0.22 %)
$ 9.18
$ 9.25
$ 9.71 x 20
$ 9.76 x 14
$ 9.25 - $ 9.84
$ 8.18 - $ 29.56
1,270,209
na
705.79M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-09-2025 08-31-2025 10-Q
2 07-09-2025 05-31-2025 10-Q
3 04-08-2025 02-28-2025 10-Q
4 01-28-2025 11-30-2024 10-K
5 10-11-2024 08-31-2024 10-Q
6 07-11-2024 05-31-2024 10-Q
7 04-10-2024 02-29-2024 10-Q
8 02-15-2024 11-30-2023 10-K
9 10-12-2023 08-31-2023 10-Q
10 07-13-2023 05-31-2023 10-Q
11 04-13-2023 02-28-2023 10-Q
12 02-09-2023 11-30-2022 10-K
13 10-06-2022 08-31-2022 10-Q
14 07-07-2022 05-31-2022 10-Q
15 04-08-2022 02-28-2022 10-Q
16 01-28-2022 11-30-2021 10-K
17 10-14-2021 08-31-2021 10-Q
18 07-13-2021 05-31-2021 10-Q
19 04-13-2021 02-28-2021 10-Q
20 02-16-2021 11-30-2020 10-K
21 10-14-2020 08-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-equal-weight-on-nurix-therapeutics-lowers-price-target-to-15
Morgan Stanley Maintains Equal-Weight on N...
10/14/2025 16:08:43

Morgan Stanley analyst Terence Flynn maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price tar...

hc-wainwright--co-maintains-buy-on-nurix-therapeutics-lowers-price-target-to-33
HC Wainwright & Co. Maintains Buy on Nurix...
10/14/2025 11:22:32

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

breaking-down-nurix-therapeutics-5-analysts-share-their-views
Breaking Down Nurix Therapeutics: 5 Analys...
10/10/2025 13:00:44

piper-sandler-maintains-overweight-on-nurix-therapeutics-lowers-price-target-to-32
Piper Sandler Maintains Overweight on Nuri...
10/10/2025 12:55:59

Piper Sandler analyst Joseph Catanzaro maintains Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and lowers the price tar...

oppenheimer-maintains-outperform-on-nurix-therapeutics-lowers-price-target-to-28
Oppenheimer Maintains Outperform on Nurix ...
10/10/2025 12:26:55

Oppenheimer analyst Matthew Biegler maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and lowers the price target...

nurix-therapeutics-posts-downbeat-q3-results-joins-orthopediatrics-levi-strauss-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Nurix Therapeutics Posts Downbeat Q3 Resul...
10/10/2025 12:02:09

why-applied-digital-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Applied Digital Shares Are Trading Hig...
10/10/2025 09:06:13

levi-strauss-usana-health-sciences-and-3-stocks-to-watch-heading-into-friday
Levi Strauss, USANA Health Sciences And 3 ...
10/10/2025 06:53:44

US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.

nurix-therapeutics-q3-eps-103-misses-088-estimate-sales-7894m-miss-16736m-estimate
Nurix Therapeutics Q3 EPS $(1.03) Misses $...
10/09/2025 20:03:13

nurix-and-gilead-advance-irak4-degrader-gs-6791-into-clinical-trials-after-preclinical-results-in-skin-disease
Nurix And Gilead Advance IRAK4 Degrader GS...
09/17/2025 11:10:23

Nurix Therapeutics, Inc. (NASDAQ:NRIX) today announced the presentation of preclinical data from GS-6791/NX-0479, a novel IRAK4...

6-analysts-assess-nurix-therapeutics-what-you-need-to-know
6 Analysts Assess Nurix Therapeutics: What...
07/31/2025 21:00:25

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

morgan-stanley-maintains-equal-weight-on-nurix-therapeutics-lowers-price-target-to-16
Morgan Stanley Maintains Equal-Weight on N...
07/15/2025 12:58:36

Morgan Stanley analyst Terence Flynn maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price tar...

a-glimpse-into-the-expert-outlook-on-nurix-therapeutics-through-5-analysts
A Glimpse Into The Expert Outlook On Nurix...
07/14/2025 21:00:20

hc-wainwright--co-maintains-buy-on-nurix-therapeutics-lowers-price-target-to-34
HC Wainwright & Co. Maintains Buy on Nurix...
07/14/2025 14:16:28

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price targ...

ubs-maintains-buy-on-nurix-therapeutics-lowers-price-target-to-26
UBS Maintains Buy on Nurix Therapeutics, L...
07/10/2025 22:10:15

UBS analyst David Dai maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $30 to $26.

amazon-to-rally-around-28-here-are-10-top-analyst-forecasts-for-thursday
Amazon To Rally Around 28%? Here Are 10 To...
07/10/2025 14:28:08

oppenheimer-maintains-outperform-on-nurix-therapeutics-lowers-price-target-to-30
Oppenheimer Maintains Outperform on Nurix ...
07/10/2025 13:14:34

Oppenheimer analyst Matthew Biegler maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and lowers the price target...

stephens--co-reiterates-overweight-on-nurix-therapeutics-maintains-30-price-target
Stephens & Co. Reiterates Overweight on Nu...
07/10/2025 12:12:11

Stephens & Co. analyst Sudan Loganathan reiterates Nurix Therapeutics (NASDAQ:NRIX) with a Overweight and maintains $30 ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 12:09:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION